The president of the California stem cell agency said today [Jan 19, 2012] "Geron has two interested buyers for its human embryonic stem cell business.
Alan Trounson told CIRM directors that at one point four parties had expressed interest but two have backed out. He did not disclose the names of any of the parties.
Geron closed at $1.70 on 412,941 shares. No price increase, no volume increase, no buyer.
Good luck in this rigged casino
No comments:
Post a Comment